The Right Option – This year, parents can choose between a vaccine given to the mother during pregnancy and a monoclonal antibody given to toddlers to immunize them against bronchiolitis
Autumn is fast approaching, and like every year at the same time, it should bring in its wake the seasonal epidemic of bronchiolitis, this respiratory condition that can be very virulent in toddlers. If since last year, it is now possible to protect infants with Beyfortus, a new option completes the arsenal of fight against bronchiolitis.
For a few days now, a new vaccine has been available: Abrysvo. Its particularity compared to Beyfortus: it is administered not to the baby but to the mother during her pregnancy. Why two strategies to combat bronchiolitis? How do they work together? Is one better than the other? 20 Minutes explains to you.
Vaccine or antibodies, “a decisive arsenal”
A major source of concern for parents of newborns, the annual bronchiolitis epidemic affects “30% of infants under 2 years old each winter,” recalls Public Health France. Most often, it is caused by the “respiratory syncytial virus (RSV), which is responsible for respiratory infections in newborns and infants that can turn into bronchiolitis, specifies the High Authority for Health (HAS). C(…) - 20minutes
Also read:
Bronchiolitis: The High Health Authority recommends either vaccinating the pregnant woman or treating the infant
Infantile “fifth disease”: France hit by a parvovirus epidemic, which killed five babies in 2024
Bronchiolitis: Data confirms the effectiveness of Sanofi’s preventive treatment
Bronchiolitis: What do we know about Beyfortus, this preventive treatment for infants?
Related News :